Jerry Williamson

Jul 20, 2018

NanoView Biosciences has appointed Jerry Williamson as CEO. Williamson succeeds David Freedman, who will remain with the firm as chief operating officer. Williamson has 30 years of experience in commercial operations, business development, and corporate management in the life science industry. He previously served as president and CEO of KEW, and as CEO and president of Metamark Genetics.